No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SMMT240719C3000
- 6.11
- +0.49+8.72%
15min DelayClose Jul 19 16:00 ET
6.11High6.11Low
6.11Open5.62Pre Close1 Volume351 Open Interest3.00Strike Price611.00Turnover0.00%IV3.70%PremiumJul 19, 2024Expiry Date5.79Intrinsic Value100Multiplier0DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.53Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Citi Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $13
Citi analyst Yigal Nochomovitz maintains $Summit Therapeutics(SMMT.US)$ with a buy rating, and maintains the target price at $13.According to TipRanks data, the analyst has a success rate of 45.3%
Dr. David Krajicek Joins Summit Partners as Executive-in-Residence
LONDON--(BUSINESS WIRE)--Global growth equity investor Summit Partners is delighted to welcome Dr. David Krajicek to the firm's Executive-in-Residence ("EIR") program. In this role, Dr. Krajicek
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?QuantumScape Corporation (NYSE:QS) stock jumped 64.34% after the company announced it entered into an
Insiders See US$5.84m Investment In Summit Therapeutics Jump Last Week
Summit Therapeutics Inc. (NASDAQ:SMMT) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 18% resulting in a US$920m addition to the company's
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 330,000 shares of
Express News | Summit Therapeutics Appoints Jeff Huber, Transformational Google and Grail Executive, to Its Board of Directors
Comments
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? ![]()
$XPeng(XPEV.US$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape(QS.US$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G(VWAGY.US$ 's battery company PowerC...
$XPeng(XPEV.US$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape(QS.US$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G(VWAGY.US$ 's battery company PowerC...
2
Today, we are looking for targets to buy Mon. after Fri's massacre.
$Summit Therapeutics(SMMT.US$
Lung cancer Pharma company's new drug shows tangible improvement over the only other medication for the most common deadly case of lung cancer.
Fundamentals are solid. The PCB is overbought, though. We set our target for $13, but gonna watch this one close. Pharma be fickle.
$A10 Networks(ATEN.US$
I feel is strongest of the day. They make software for things like data-center optimization. Wonde...
$Summit Therapeutics(SMMT.US$
Lung cancer Pharma company's new drug shows tangible improvement over the only other medication for the most common deadly case of lung cancer.
Fundamentals are solid. The PCB is overbought, though. We set our target for $13, but gonna watch this one close. Pharma be fickle.
$A10 Networks(ATEN.US$
I feel is strongest of the day. They make software for things like data-center optimization. Wonde...
4
Read more